Related Experiment Video

Updated: Aug 15, 2026

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies
11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

Recurrent allograft disease: viral hepatitis

Marina Berenguer1

  • 1Hospital Universitario La FE, Servicio de Gastroenterología y Hepatología, Valencia, Spain. mbhaym@teleline.es

Acta Gastro-Enterologica Belgica
|November 5, 2005
PubMed

Insights

Recurrent hepatitis C after liver transplantation (LT) remains a significant challenge due to the lack of effective prevention strategies. This leads to rapid graft fibrosis and reduced patient survival, unlike hepatitis B which has successful preventative measures.

Area of Science:

  • Hepatology and Transplant Surgery
  • Viral Hepatitis Research
  • Immunology and Infectious Diseases

Background:

  • Viral hepatitis is the primary indication for liver transplantation (LT).
  • Preventing allograft reinfection is crucial for post-transplantation outcomes.
  • Hepatitis B recurrence is effectively managed, but hepatitis C recurrence poses a growing problem.

Purpose of the Study:

  • To highlight the challenges in preventing recurrent hepatitis C post-liver transplantation.
  • To discuss the limitations of current prophylactic and therapeutic strategies for hepatitis C.
  • To underscore the impact of recurrent hepatitis C on graft and patient survival.

Main Methods:

  • Review of current literature on viral hepatitis recurrence after LT.
  • Analysis of outcomes in patients with hepatitis B versus hepatitis C recurrence.
  • Evaluation of existing antiviral therapies and their toxicities.

Main Results:

  • Hepatitis B recurrence is effectively prevented with immunoglobulins and antivirals.
  • Hepatitis C recurrence is nearly invariable due to lack of effective prophylaxis.
  • Recurrent hepatitis C leads to rapid allograft fibrosis and end-stage liver disease.

Conclusions:

  • There is an urgent need for effective prophylactic therapies against recurrent hepatitis C.
  • Current treatments for recurrent hepatitis C have significant toxicities limiting efficacy.
  • Recurrent hepatitis C significantly decreases graft survival, increases re-transplantation rates, and reduces patient survival.

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...